FDA Drug Recalls

Recalls / Class II

Class IID-1114-2019

Product

LOSARTAN POTASSIUM TABLETS, USP, 25 mg, a) 90-count (NDC: 13668-113-90), b) 1000-count (NDC: 13668-113-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

Affected lot / code info
Count, lots, expiry: [90-count bottle ] Lots 4DU1E005, 4DU1E006, 4DU1E008, exp 1/31/2021; Lots 4DU1E007, exp 1/31/2021

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.

Recalling firm

Firm
Torrent Pharma Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
150 Allen Rd Ste 102, N/A, Basking Ridge, New Jersey 07920-3856

Distribution

Quantity
133,992 bottles
Distribution pattern
Nationwide USA and Puerto Rico

Timeline

Recall initiated
2019-02-28
FDA classified
2019-04-10
Posted by FDA
2019-04-17
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-1114-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.